In our sample, we evaluated the immunohistochemical expression of α-SMA in biopsies of patients diagnosed with SCCHN, which allowed us to identify CAFs in the tumour stroma and evaluate its distribution. The gene discussed is ACTA1; the disease is neoplasm.